title: Recurrent pyelonephritis due to NDM-1 metallo-beta-lactamase producing Pseudomonas aeruginosa in a patient returning from Serbia, France, 2012.
abstract: We describe the first isolation in France of a New-Delhi metallo-beta-lactamase-1 (NDM-1) producing Pseudomonas aeruginosa. In March 2012, a patient with history of prior hospitalisation in Serbia was diagnosed in France with acute pyelonephritis due to NDM-1 producing P. aeruginosa. Clinical and microbiological cure was obtained under appropriate antibiotic treatment. Two months later, she presented with a recurrence due to the same bacteria, with a favourable evolution. During both hospitalisations, contact isolation precautions were implemented and no cross-transmission was observed.
authors.affiliation: Service des maladies infectieuses et tropicales, Hopital d instruction des armees Begin, Saint-Mande, France. claraflateau@yahoo.fr
authors.forename: C
authors.initials: C
authors.lastname: Flateau
authors.forename: F
authors.initials: F
authors.lastname: Janvier
authors.forename: H
authors.initials: H
authors.lastname: Delacour
authors.forename: S
authors.initials: S
authors.lastname: Males
authors.forename: C
authors.initials: C
authors.lastname: Ficko
authors.forename: D
authors.initials: D
authors.lastname: Andriamanantena
authors.forename: K
authors.initials: K
authors.lastname: Jeannot
authors.forename: A
authors.initials: A
authors.lastname: Merens
authors.forename: C
authors.initials: C
authors.lastname: Rapp
mesh_terms: D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D005602:France; D006760:Hospitalization; D006801:Humans; D007710:Klebsiella Infections / Q000382:microbiology; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000235:genetics* / Q000302:isolation & purification; D011704:Pyelonephritis / Q000188:drug therapy / Q000382:microbiology*; D012008:Recurrence; D055771:Serbia; D014195:Travel; D014546:Urinary Catheterization / Q000009:adverse effects; D014552:Urinary Tract Infections / Q000382:microbiology / Q000517:prevention & control; D018440:beta-Lactam Resistance / Q000187:drug effects; D001618:beta-Lactamases / Q000235:genetics*
chemical_list: D000900:Anti-Bacterial Agents; D001618:beta-Lactamases; C552864:beta-lactamase NDM-1